image description

Category: Press Releases

Lupus Research Alliance 2023 Dr. William E. Paul Distinguished Innovator Award Granted to Yale School of Medicine Researcher Akiko Iwasaki, Ph.D.

NEW YORK, NY, January 30, 2024 — Research Will Explore How Ancient Viral Remnants in Our DNA Trigger Lupus The Lupus Research Alliance (LRA) is pleased to grant the 2023 Dr. William E. Paul Distinguished Innovator Award (DIA) to Akiko Iwasaki, Ph.D., Sterling Professor of Immunobiology at the Yale School of Medicine. Dr. Iwasaki will […] Read More

Lupus Research Alliance Gala Raises $2 Million for Research to Transform Treatment

NEW YORK, NY, November 21, 2023 – This year’s Lupus Research Alliance (LRA) Breaking Through Gala raised $2 million for lupus research and brought the hope of tremendous progress that’s improving lupus treatment while driving to a cure.  The annual celebration began with a powerhouse performance and moving tribute to lupus warriors by multi-talented pianist, […] Read More

LRA Highlights Groundbreaking Lupus Research at ACR Convergence 2023

SAN DIEGO, CA, Nov. 6, 2023 – This information is brought to you by the Lupus Research Alliance and Lupus Therapeutics and is not sponsored by, nor a part of, the American College of Rheumatology.  30+ presentations of studies funded by the LRA spanning a broad spectrum of research areas Positive results from Phase 2/3 clinical studies supported […] Read More

Positive One-Year Results of PALS Program Published in Prestigious Rheumatology Journal

NEW YORK, NY, October 26, 2023 — The clinical research affiliate of the Lupus Research Alliance, Lupus Therapeutics, announced successful results of the Patient Advocates for Lupus Studies (PALS) pilot study that were published in ACR Open Rheumatology. The study showed that 12 months after finishing the PALS program, participants’ knowledge about lupus clinical trials had […] Read More

Lupus Therapeutics Partners with AbbVie on Clinical Trial Recruitment Efforts in SLE Through LuCIN Lupus Clinical Trial Network 

NEW YORK, NY, October 24, 2023 — The clinical research affiliate of the Lupus Research Alliance, Lupus Therapeutics, announced a partnership with AbbVie Inc. for the Phase 3 development of upadacitinib (RINVOQ®) as a potential treatment for people living with systemic lupus erythematosus (SLE). Lupus Therapeutics will assist with recruiting participants to join the study, […] Read More

The Lupus Research Alliance Walk with Us to Cure Lupus Takes Off at the Intrepid Museum

NEW YORK, NY, October 20, 2023 — Thousands of supporters will join together Saturday, October 21 at the Intrepid Museum (formerly called the Intrepid Sea, Air and Space Museum) to celebrate the 20th Anniversary of the Lupus Research Alliance (LRA) 2023 New York City Walk with Us to Cure Lupus. Registration remains open through Walk Day at www.lupuswalknyc.org. While the well-attended annual […] Read More

Lupus Therapeutics Announces Partnership to Support the Evaluation of Natural Killer (NK) Cell Therapy in Lupus Nephritis

NEW YORK, NY, October 17, 2023 — The clinical research affiliate of the Lupus Research Alliance, Lupus Therapeutics, announced a partnership with the biopharmaceutical company Nkarta, Inc. in developing the engineered natural killer (NK) cell therapy NKX019 as a potential treatment for people with refractory lupus nephritis who have not responded to standard treatment. Read More

NFL’s Willie Colon Golf Outing Drives Lupus Awareness with LRA

SUMMIT, NJ, July 17, 2023 — Former Super Bowl Champion and Mad Dog Sports radio personality Willie Colon is hosting today the 9th Annual Willie Colon Golf Outing crafted by Tito’s Handmade Vodka for the Lupus Research Alliance (LRA). The event drives lupus awareness and tees up the opening of the Fall season of the […] Read More